Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e17ac3e790b960c8a589610fa3d767e6 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-31 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-8182 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-8158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-22 |
filingDate |
2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a2e9a70daaf6a9e03ac5891c1069530 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41aff1f0e3373d8e5ff867389466fcdb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_374b93084a30201c9cf794f70ffc124e |
publicationDate |
2022-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11278478-B2 |
titleOfInvention |
Oral care compositions and methods for increasing stability of the same |
abstract |
Anhydrous oral care compositions and methods for preventing phase separation in the anhydrous oral care composition are disclosed. The oral care composition may include an orally acceptable vehicle, a thickening system, and a whitening agent. The orally acceptable vehicle may include propylene glycol, and the thickening system may include a polymeric thickener. The polymeric thickener may be or include a copolymer of 2-acrylamidomethylpropanesulphonic acid or a salt thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022211595-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021401699-A1 |
priorityDate |
2017-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |